Gladius Capital Management’s Cartesian Therapeutics RNAC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-571	Closed	-$19.2K	–	348
2023 Q2	$19.2K	Buy	+571	New	+$19.2K	﹤0.01%	220